Please login to the form below
Dementia Discovery Fund
This page shows the latest Dementia Discovery Fund news and features for those working in and with pharma, biotech and healthcare.
Bicycles Therapeutics enters dementia discovery with venture capital fund
Ambitious UK biotech expands research scope. UK biotech rising star Bicycle Therapeutics has announced a new alliance with the Dementia Discovery Fund (DDF) to use its novel platform to develop new ... A special DDF panel of neuroscientists and experts
Latest news
-
Daily Brief: Dementia Fund hits $350m mark, hard Brexit could cost £100bn in trade and troublesome results for Pfizer’s Ibrance
The Dementia Discovery Fund (DDF) confirmed yesterday that it had raised £250m ($350m), boosted by a $60m investment from US non-profit organisation AARP, which aims to help older people live ... The fundraising far exceeded its initial target of $200m (
-
British Business Bank sets up £2.5bn fund for ‘unicorn’ firms
A new UK government-backed investment vehicle to provide long-term capital for British businesses has been launched, with a fund backing dementia drug developers among the first to benefit. ... The Dementia Discovery Fund is one of two VCs given funding
-
Pfizer drops neuroscience R&D, cutting 300 jobs
It will also set up a dedicated venture capital fund to invest in other companies carrying out neuroscience R&D and “support continued efforts to advance the field”. ... Pfizer is already one of the founder members of the cross-company Dementia
-
Woodford investment pushes Dementia Discovery Fund to £100m
Fund aims to back 40 projects over its 15-year term. Thanks to a £15m pledge from Neil Woodford's investment group, the public-private Dementia Discovery Fund (DDF) has now ... therapies. The DDF's chief scientific officer - former Takeda drug discovery
-
GSK and J&J back new UK dementia discovery fund
Pharma giants collaborate with government to find new treatments. GlaxoSmithKline, Johnson &Johnson and Pfizer have signed up to support a new UK government dementia discovery fund. ... The fund will work with universities, academic institutes and the
More from news
Approximately 2 fully matching, plus 7 partially matching documents found.
Latest Intelligence
-
Detecting Alzheimer’s ahead of a cure
A new company has been created from Alzheimer’s Research UK’s Drug Discovery Alliance, which will build on the work of the charity’s UCL Drug Discovery Institute. ... This newly formed biotech company, named AstronauTx, has recently received £6.5m
-
Brain power: fresh approaches to Alzheimer’s drug discovery
The venture capital approach to dementia research. The Dementia Discovery Fund is a venture capital fund focused on discovering and developing novel therapies for dementia, first set up in October 2015. ... Angus Grant, CEO of the Dementia Discovery Fund,
-
30 Women Leaders in UK Healthcare (part 2)
In the meantime, she is challenging not just the accepted ways of conducting drug discovery, but also some of the male behaviour that can mar the working environment. ... the UK’s new Dementia Discovery Fund (DDF) and serves on the DDF Investment
-
The world is our laboratory
This year, through J&J Innovation, we will invest $10m into the UK government-led Global Dementia Discovery Fund, supporting innovative research into the area. ... This was set up in 2013 to identify innovative solutions for dementia care.
-
Pharma deals in March 2015
This month saw GSK invest $25m, J&J $10m and the UK Government $22m into the Dementia Discovery fund, a joint initiative also including Lilly, Biogen and Pfizer to research treatments
More from intelligence
Approximately 1 fully matching, plus 4 partially matching documents found.
Latest appointments
-
New hires at EMA, Gilead and BeiGene
Most recently, Grant was chief executive officer of the Dementia Discovery Fund (DDF), a specialist venture capital fund focused on therapeutics for age-related dementias and neurodegenerative disease.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Forecasting in Forgotten Markets
To help address a lack of investment in novel dementia science a new £100M Dementia Discovery Fund ( ) was launched towards the end of last year. ... Managed by SV Life Sciences the fund is focused primarily on Phase I and II research and aims to help
More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Gilead agrees $21bn buyout of Immunomedics
- Regeneron launches phase 3 COVID-19 antibody trial in the UK
- Regeneron launches phase 3 COVID-19 antibody trial in the UK
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Roche’s Ocrevus boasts positive long-term data in MS
- First patients dosed with COVID-19 vaccine from SpyBiotech and Serum Institute of India
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Envision Pharma Group scoops two Silvers at the PM Society Digital Awards 2020
- Alone we can do so little, together we can do so much
- What can't we afford to treat anymore?
- OPEN VIE is awarded a Bronze Award at the PM Society Digital Awards 2020
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
PMHub
Onyx Health Ltd
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...
Latest intelligence
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
- Alone we can do so little, together we can do so much
- Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
- 7 important considerations for creating an inclusive clinical trial website
- You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...
Quick links
Infographics
